Your browser doesn't support javascript.
loading
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.
Andres-Ejarque, Rosa; Ale, Hira Bahadur; Grys, Katarzyna; Tosi, Isabella; Solanky, Shane; Ainali, Chrysanthi; Catak, Zeynep; Sreeneebus, Hemawtee; Saklatvala, Jake; Dand, Nick; de Rinaldis, Emanuele; Chapman, Anna; Nestle, Frank O; Barnes, Michael R; Warren, Richard B; Reynolds, Nick J; Griffiths, Christopher E M; Barker, Jonathan N; Smith, Catherine H; Di Meglio, Paola.
Afiliação
  • Andres-Ejarque R; St. Johns Institute of Dermatology, Kings College London, London, United Kingdom.
  • Ale HB; St. Johns Institute of Dermatology, Kings College London, London, United Kingdom.
  • Grys K; St. Johns Institute of Dermatology, Kings College London, London, United Kingdom.
  • Tosi I; NIHR Biomedical Research Centre, Guys & St Thomas NHS Foundation Trust & King's College London, London, UK.
  • Solanky S; St. Johns Institute of Dermatology, Kings College London, London, United Kingdom.
  • Ainali C; NIHR Biomedical Research Centre, Guys & St Thomas NHS Foundation Trust & King's College London, London, UK.
  • Catak Z; St. Johns Institute of Dermatology, Kings College London, London, United Kingdom.
  • Sreeneebus H; St. Johns Institute of Dermatology, Kings College London, London, United Kingdom.
  • Saklatvala J; DIGNOSIS Limited, London, UK.
  • Dand N; St. Johns Institute of Dermatology, Kings College London, London, United Kingdom.
  • de Rinaldis E; NIHR Biomedical Research Centre, Guys & St Thomas NHS Foundation Trust & King's College London, London, UK.
  • Chapman A; St. Johns Institute of Dermatology, Kings College London, London, United Kingdom.
  • Nestle FO; NIHR Biomedical Research Centre, Guys & St Thomas NHS Foundation Trust & King's College London, London, UK.
  • Barnes MR; Department of Medical and Molecular Genetics, Kings College London, London, UK.
  • Warren RB; Department of Medical and Molecular Genetics, Kings College London, London, UK.
  • Reynolds NJ; NIHR Biomedical Research Centre, Guys & St Thomas NHS Foundation Trust & King's College London, London, UK.
  • Griffiths CEM; Sanofi, Cambridge, MA, USA.
  • Barker JN; Dermatology Department, Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, London, UK.
  • Smith CH; St. Johns Institute of Dermatology, Kings College London, London, United Kingdom.
  • Di Meglio P; NIHR Biomedical Research Centre, Guys & St Thomas NHS Foundation Trust & King's College London, London, UK.
Nat Commun ; 12(1): 7358, 2021 Dec 16.
Article em En | MEDLINE | ID: mdl-34916493
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article